Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Kevin O'Hayer"'
Autor:
Rebecca Kristeleit, Howard Burris, Kristen Spencer, Sarina Piha-Paul, Hans Prenen, Tara Mitchell, David Pinato, Solmaz Sahebjam, Donna Graham, Nuria Kotecki, Eric Van Cutsem, Brant Delafontaine, Thomas Karasic, Jeannie Daniel, Kevin O’Hayer, Ryan Geschwindt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/7ed5aa6600e64e098a5e3fe1502b2f72
Autor:
Jason J. Luke, Marwan Fakih, Charles Schneider, E. Gabriela Chiorean, Johanna Bendell, Rebecca Kristeleit, Razelle Kurzrock, Sarah P. Blagden, Irene Brana, Laura W. Goff, Kevin O’Hayer, Ryan Geschwindt, Michael Smith, Feng Zhou, Aung Naing
Publikováno v:
Scientia
Background Indoleamine 2,3-dioxygenase 1 (IDO1), an interferon-inducible enzyme, contributes to tumor immune intolerance. Immune checkpoint inhibition may increase interferon levels; combining IDO1 inhibition with immune checkpoint blockade represent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a86bc969a7907b279383b86ec75a315
https://hdl.handle.net/11351/9837
https://hdl.handle.net/11351/9837
Autor:
Gregory Hollis, Wenqing Yao, Reid Huber, Peggy Scherle, Jeff Jackson, Swamy Yeleswaram, Cindy Marando, Ryan Geschwindt, Pramod Thekkat, Yue Zhang, Christina Stevens, Luping Lin, Darlise DiMatteo, Mark Rupar, Gengjie Yang, Chrysi Kanellopoulou, Stephen Rubin, Kevin O'Hayer, Maxim Soloviev, Sharon Diamond, Jingwei Li, Yan-ou Yang, Maryanne Covington, Elham Behshad, Kanishk Kapilashrami, Nina Zolotarjova, Alla Volgina, Hao Liu, Susan Spitz, Jonathan Rios-Doria, Richard Wynn, Phillip C.C. Liu, Liang-Chuan S. Wang, Liangxing Wu, Holly K. Koblish
Supplementary Table from Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76bbcf100cd3199695d65a7a2d3df77e
https://doi.org/10.1158/2159-8290.22540981.v1
https://doi.org/10.1158/2159-8290.22540981.v1
Autor:
Gregory Hollis, Wenqing Yao, Reid Huber, Peggy Scherle, Jeff Jackson, Swamy Yeleswaram, Cindy Marando, Ryan Geschwindt, Pramod Thekkat, Yue Zhang, Christina Stevens, Luping Lin, Darlise DiMatteo, Mark Rupar, Gengjie Yang, Chrysi Kanellopoulou, Stephen Rubin, Kevin O'Hayer, Maxim Soloviev, Sharon Diamond, Jingwei Li, Yan-ou Yang, Maryanne Covington, Elham Behshad, Kanishk Kapilashrami, Nina Zolotarjova, Alla Volgina, Hao Liu, Susan Spitz, Jonathan Rios-Doria, Richard Wynn, Phillip C.C. Liu, Liang-Chuan S. Wang, Liangxing Wu, Holly K. Koblish
Supplementary Figure from Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::170fab3f863c9be0aad6f9e19f25879b
https://doi.org/10.1158/2159-8290.22540984.v1
https://doi.org/10.1158/2159-8290.22540984.v1
Autor:
Gregory Hollis, Wenqing Yao, Reid Huber, Peggy Scherle, Jeff Jackson, Swamy Yeleswaram, Cindy Marando, Ryan Geschwindt, Pramod Thekkat, Yue Zhang, Christina Stevens, Luping Lin, Darlise DiMatteo, Mark Rupar, Gengjie Yang, Chrysi Kanellopoulou, Stephen Rubin, Kevin O'Hayer, Maxim Soloviev, Sharon Diamond, Jingwei Li, Yan-ou Yang, Maryanne Covington, Elham Behshad, Kanishk Kapilashrami, Nina Zolotarjova, Alla Volgina, Hao Liu, Susan Spitz, Jonathan Rios-Doria, Richard Wynn, Phillip C.C. Liu, Liang-Chuan S. Wang, Liangxing Wu, Holly K. Koblish
Blocking the activity of the programmed cell death protein 1 (PD-1) inhibitory receptor with therapeutic antibodies against either the ligand (PD-L1) or PD-1 itself has proven to be an effective treatment modality for multiple cancers. Contrasting wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6486db56a65286928bd5907136280e12
https://doi.org/10.1158/2159-8290.c.6549529
https://doi.org/10.1158/2159-8290.c.6549529
Autor:
Gregory Hollis, Wenqing Yao, Reid Huber, Peggy Scherle, Jeff Jackson, Swamy Yeleswaram, Cindy Marando, Ryan Geschwindt, Pramod Thekkat, Yue Zhang, Christina Stevens, Luping Lin, Darlise DiMatteo, Mark Rupar, Gengjie Yang, Chrysi Kanellopoulou, Stephen Rubin, Kevin O'Hayer, Maxim Soloviev, Sharon Diamond, Jingwei Li, Yan-ou Yang, Maryanne Covington, Elham Behshad, Kanishk Kapilashrami, Nina Zolotarjova, Alla Volgina, Hao Liu, Susan Spitz, Jonathan Rios-Doria, Richard Wynn, Phillip C.C. Liu, Liang-Chuan S. Wang, Liangxing Wu, Holly K. Koblish
Supplementary Data from Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5739e2f7911a281a155113d1f5d765bd
https://doi.org/10.1158/2159-8290.22540987
https://doi.org/10.1158/2159-8290.22540987
Autor:
Jonathan R. Brody, George C. Prendergast, Charles J. Yeo, Jordan M. Winter, Laura Mandik-Nayak, Benjamin E. Leiby, Tatiana Villatoro, Mark Curtis, Theresa P. Yeo, Harish Lavu, Joseph A. Cozzitorto, Kevin O'Hayer, Eric Londin, Kei Nagatomo, James B. DuHadaway, Erika Sutanto-Ward, Alexander J. Muller, Avinoam Nevler
Flow cytometry graphs (black and white line and dot drawing)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a14bdcc0c6fe4d185c9df01a8ff333bb
https://doi.org/10.1158/1078-0432.22474127.v1
https://doi.org/10.1158/1078-0432.22474127.v1
Autor:
Jonathan R. Brody, George C. Prendergast, Charles J. Yeo, Jordan M. Winter, Laura Mandik-Nayak, Benjamin E. Leiby, Tatiana Villatoro, Mark Curtis, Theresa P. Yeo, Harish Lavu, Joseph A. Cozzitorto, Kevin O'Hayer, Eric Londin, Kei Nagatomo, James B. DuHadaway, Erika Sutanto-Ward, Alexander J. Muller, Avinoam Nevler
Purpose:Heritable genetic variations can affect the inflammatory tumor microenvironment, which can ultimately affect cancer susceptibility and clinical outcomes. Recent evidence indicates that IDO2, a positive modifier in inflammatory disease models,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6436d7fc32241df84282af6cf83819d0
https://doi.org/10.1158/1078-0432.c.6528692.v1
https://doi.org/10.1158/1078-0432.c.6528692.v1
Autor:
Jonathan R. Brody, George C. Prendergast, Charles J. Yeo, Jordan M. Winter, Laura Mandik-Nayak, Benjamin E. Leiby, Tatiana Villatoro, Mark Curtis, Theresa P. Yeo, Harish Lavu, Joseph A. Cozzitorto, Kevin O'Hayer, Eric Londin, Kei Nagatomo, James B. DuHadaway, Erika Sutanto-Ward, Alexander J. Muller, Avinoam Nevler
Table S1. Sequencing primers for IDO2 functional polymorphisms. Table S2. IDO2 genotype functionality definitions. A three-tier scale describes possible genotype combinations of IDO2 functional polymorphisms.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b56bf9440e38bc38318e0564f7de010
https://doi.org/10.1158/1078-0432.22474118.v1
https://doi.org/10.1158/1078-0432.22474118.v1
Autor:
Jonathan R. Brody, George C. Prendergast, Charles J. Yeo, Jordan M. Winter, Laura Mandik-Nayak, Benjamin E. Leiby, Tatiana Villatoro, Mark Curtis, Theresa P. Yeo, Harish Lavu, Joseph A. Cozzitorto, Kevin O'Hayer, Eric Londin, Kei Nagatomo, James B. DuHadaway, Erika Sutanto-Ward, Alexander J. Muller, Avinoam Nevler
Supplemental legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04c867c09709ca219559566bc3a156fa
https://doi.org/10.1158/1078-0432.22474115
https://doi.org/10.1158/1078-0432.22474115